The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial. (nature.com)

Authors: Mummery CJ … Salvadore G Journal: Nature Medicine Published: 2026-05-01 DOI: https://doi.org/10.1038/s41591-026-04273-1